Form 4/A for CMPX Compass Therapeutics, Inc.
Accepted 2026-04-30 16:00:25 ET · period of report 2026-04-29 · accession 0001171843-26-002893 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2026-04-30 16:00 | 2026-04-29 | CMPX | Anderman Jonathan | GC | P - Purchase | $1.89 | +25.0K | 196.0K | +15% | +$47.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-04-29 | P | A | 25,000 | $1.89 | 196,000 | D | — | — | (F1) 150,000 of the shares represents unvested restricted stock units ("RSU") granted on January 2, 2026. Each RSU represents a contingent right to receive one share of common stock. The award is subject to service-based vesting conditions and vests in four equal annual installments, with the first installment vested on January 2, 2027. |